We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Augusto Miravalle

Augusto Miravalle MD, FAAN

Clinical Associate Professor of Neurology; Liaison for Neurology, Fort Collins Branch, University of Colorado Denver School of Medicine, Aurora, Colorado

Dr. Miravalle is an Associate Professor of Clinical Neurology at the University of Colorado. He provides care to patients at Advanced Neurology of Colorado. Dr. Miravalle is a board-certified neurologist who sub-specializes in Multiple Sclerosis.

Dr. Miravalle received his Medical Degree from the University of La Plata, Argentina. He completed his Neurology Residency training at Loyola University, Chicago where he served as Chief Resident of Education. He subsequently completed a Neuroimmunology Fellowship at Harvard University in Boston and a Fellowship in Medical Education at the University of Rochester, New York. Dr. Miravalle is the recipient of the 2012 American Neurological Association Medical Education Fellowship Award, 2015 American Academy of Neurology Research in Education Award, and 2015 American Board of Psychiatry and Neurology Faculty Education Innovation Award.

Dr. Miravalle has been involved in both clinical and science-based research in the field of Multiple Sclerosis and Neuroimmunology. He is a member of many professional societies and advisory boards. He is frequently invited as speaker at national and international meetings. He has published numerous scientific articles and serves as a consultant to various scientific organizations.

Disclosures

Dr Miravalle received funding and honoraria from EMD Serono, Genzyme, Genentech, Biogen, Alexion, and Bristol Myers Squibb. 

Recent Contributions to PracticeUpdate:

  1. Skin Reactions in Patients With MS Receiving Cladribine